慢性肾脏病5期患者25-羟维生素D3不足与缺乏
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:


Insufficiency and deficiency of 25-hydroxyvitamin D3 in patients with chronic kidney disease at stage 5
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 评估慢性肾脏病(CKD)5期患者25-羟维生素D3[25 (OH) D3]不足与缺乏的患病率及其影响因素.方法 对本院96例CKD 5期患者的病史、实验室检查结果等进行回顾性分析.纳入研究的变量包括:血25 (OH) D3检测值,血白细胞(WBC)、血红蛋白(Hb)、血清尿素氮(BUN)、血清肌酐(Scr)、二氧化碳结合力(CO2CP)、血清白蛋白(Alb)、碱性磷酸酶(ALP)、总胆固醇(TCH)、高密度脂蛋白(HDL-C)、低密度脂蛋白(LDL-C)、甘油三脂(TG)、钙、磷、全段甲状旁腺激素(iPTH)等.分析25 (OH) D3水平与各项观察指标间的关系.结果 96例CKD 5期患者的25 (OH) D3平均水平为33.25(24.85~ 44.30) nmol/L,显著低于正常值(P<0.01);非透析患者、维持性血液透析(以下简称血透)患者、维持性腹膜透析(以下简称腹透)患者25-羟维生素D3水平分别为32.70(25.30~43.70) nmol/L、37.00(29.20~ 48.65)nmoL/L和27.05(19.20 ~ 35.37) nmol/L.CKD5期患者的25 (OH) D3不足患病率为32.29%;在非透析、血透、腹透患者中分别为27.91%、45.45%和20%;CKD5期患者25 (OH) D3缺乏患病率为64.58%,在非透析、血透、腹透患者中分别为67.44%、51.52%和80%;25 (OH) D3缺乏及不足患病率为96.88%,非透析、血透、腹透患者中分别为95.35%、96.97%和100%,各患病率三组间差异无统计学意义.单因素相关分析结果显示,25 (OH) D3水平与Hb(r=0.222)、Alb(r=0.398)相关(P<0.05).多元线性回归分析结果显示,Alb水平与25 (OH) D3水平呈正相关.结论 CKD5患者的维生素D缺乏和不足患病率高,普遍存在.Alb是CKD5期患者维生素D水平不足或缺乏的独立影响因素.

    Abstract:

    Objectives To evaluate the prevalence of insufficiency and deficiency of 25-hydroxyvitamin D3 [25 (OH) D3] in patients with chronic kidney diseases (CKD) at stage 5,and to analyze its influencing factors.Methods General data and laboratory test results of 96 inpatients with stage 5 CKD were analyzed retrospectively.Levels of 25 (OH) D3,white blood cell (WBC),hemoglobin (Hb),urea nitrogen (BUN),serum creatinine (Scr),carbon dioxide combining power (CO2 CP),albumin (Alb),alkaline phosphatase (ALP),total cholesterol (TCH),high density lipoprotein (HDL-C),low density lipoprotein (LDL-C),triglycerides (TG),calcium (Ca),phosphorus (P)and intact parathyroid hormone (iPTH) in palasma wewe collected.Correlation between 25 (OH) D3 and other parameters were analyzed.Results The average level of 25 (OH) D3 in total 96 patients with stage 5 CKD was 33.25(24.85,44.30) nmol/L,which was significantly lower than normal level (P < 0.01).These patients were divided into three groups:patients without dialysis,patients with maintained hemodialysis(HD) and patients with maintained peritoneal dialysis(PD).The 25(OH) D3 levels of patients in those three groups were 32.70 (25.30,43.70) nmol/L,37.00 (29.20,48.65)nmol/L and 27.05 (19.20,35.37) nmol/L respectively.The prevalence of 25 (OH) D3 insufficiency of all patients was 32.29%,and in the three groups were 27.91%,45.45% and 20% respectively.The prevalence of deficiency 25(OH) D3 of all was 64.58%,and in the three groups were 67.44%,51.52% and 80% respectively.The prevalence of decreased 25(OH) D3 level of all the patients was 96.88%,and that of the three groups were 95.35%,96.97% and 100%.Single factor correlation analysis demonstrated that the 25 (OH) D3 level was correlated with Hb level (r =0.222),Alb level (r =0.398) (P < 0.05).Multiple linear regression analysis showed that Alb level was positively correlated with 25 (OH) D3.Conclusions The prevalence of insufficiency and deficiency of 25 (OH) D3 in patients with stage 5 CKD is quite high.Alb is the independent risk factor for 25 (OH) D3 level in patients with stage 5 CKD.

    参考文献
    相似文献
    引证文献

引用格式: 韦妙,冯曦.慢性肾脏病5期患者25-羟维生素D3不足与缺乏[J].国际泌尿系统杂志,2016,(6):895-899.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数: